Payment & Shipping Terms | Supply Capacity |
Payment Terms: | T/T, WU | Production Capacity: | 1000kg/year |
Min. Order: | 1 Gram | Packing: | according to the customer's requirements |
Means of Transport: | Ocean, Air, Land | Delivery Date: | 7 days |
Afatinib
CAS 439081-18-2
Afatinib is a potent and irreversible dual inhibitor of epidermal growth factor receptor and human epidermal growth factor receptor 2 tyrosine kinase. This product is suitable for the treatment of the following patients: 1. Local advanced or metastatic non-small cell lung cancer with EGFR receptor gene sensitive mutation, 2. Local advanced or metastatic squamous cell lung cancer without EGFR tyrosine kinase inhibitor treatment during or after chemotherapy with platinum.
We can customize according to customer's requirement
if you have any question pls mail us or call us.
